Medtech

Stefan Dräger, CEO of Lübeck-based medical technology firm Drägerwerk, views the planned EU ban on forever chemicals as the biggest threat to his company. The family-owned business is benefiting from the shift in defense policy. Dräger has rejected orders such as for the Kremlin hospital.